Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Elevance Health, Inc.
Elevance Health executive Mark Kaye reported a change in beneficial ownership of securities on October 22, 2026. This filing is a standard Form 4 disclosure regarding insider stock holdings.…more
Elevance Health, Inc.
Elevance Health, Inc. insider Kaye Mark has filed an SEC Form 144 to report a proposed sale of securities. This filing represents a standard disclosure regarding the disposition of shares by an insider.…more
Elevance Health, Inc.
Elevance Health has filed its 10-Q quarterly report for the period ending September 30, 2026. The filing includes certifications from the CEO and CFO regarding the accuracy of financial statements and the effectiveness of internal controls over financial reporting.…more
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Elevance Health Highlights Commercial Growth Offsetting Medicaid Attrition…more
Elevance Health stated that growth in its commercial fee-based membership is offsetting anticipated attrition in its Medicaid business. The company also reaffirmed its commitment to maintaining a 2% to 4% margin target for its Medicaid segment.…more
●●●●●●●● ●●●●● ●●●●●●
Elevance Health reported that its third-quarter Medicaid performance exceeded expectations, driven primarily by recent rate adjustments. The company expects Medicaid margins to improve by 2027 as reimbursement rates better align with cost trends.…more
●●●●●●●● ●●●●● ●●●●●●
Elevance Health reported third-quarter adjusted EPS and revenue that both surpassed analyst expectations. The company demonstrated growth with a 15.92% increase in EPS and a 0.70% rise in revenue compared to the same period last year.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.